Newron today announced its financial results and operational highlights for the business year ended Dec. 31, 2025, and ...

PolyBio Research Foundation today announced the launch of VIPER (Viral Immunopathogenesis and Persistence Repeat Donor Cohort ...

HII’s Newport News Shipbuilding division has completed builder’s sea trials for the aircraft carrier John F. Kennedy (CVN 79) ...

With a clear pathway toward FDA submission and strong execution underway, we believe BlinkLab is well positioned to transform how autism is assessed in clinical practice.” — BlinkLab CEO and Managing ...

In this article, we will discuss the 9 Best Psychedelic Stocks to Buy in 2026. The AdvisorShares Psychedelics ETF, a fund ...

With thoracic oncology in the middle of a combinatorial revolution—EGFR-targeted doublets and triplets, a maturing ...

CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company d ...

When Aardvark Therapeutics announced earlier this month that it was pausing a phase 3 trial of its lead metabolic candidate, ...

A jury began deliberations Monday in a landmark trial in New Mexico where social media conglomerate Meta is accused of ...

A new longevity trial combines five days of exercise a week with one supplement and one drug. It's all designed to improve healthy aging.

Palantir rose after the Pentagon designated its Maven AI platform a program of record, while a new U.K. regulatory trial ...

Until mid-January it wasn’t a guarantee that Christian Moss would have another chapter in his college football journey. The 6 ...